The Federal Trade Commission (FTC) on Monday proposed restrictions on dialysis service provider DaVita under the agency’s newly reinstated “prior approval” policy aimed at curbing anticompetitive mergers.
FTC marks revived ‘prior approval’ merger stance with proposed limits on DaVita
